Skip to content

DR .P.VAN DER REST

Active
Private limited companyfounded 2011active for 15 yearsRue des Jardins-d'Annevoie 32, 5537 Anhée, BelgiumKBO/BCE: BE 0833.843.177
Summary

DR .P.VAN DER REST has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €174,119 and a net result of €34,260. Equity is growing by about 31% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
“En assurant la gestion d’un centre médical ou d’un cabinet médical,en ce compris l’acquisition,la…” (deed in French)
From the articles, 7 activitiesNo NACE code in the KBO yet1 site
Size
€243,257total assets 2025
Equity
€174,119
Profit
€34,260
Turnover not published (micro format)
Financial health
89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
  • Charles van der RESTDirector
2025 accounts filed 28 days late1 of 2 deeds summarised
Why 89raises riskLast filed accounts filed 28 days late; 2 of the last 3 lateLiquidity: current ratio 3.45, cash €3,062, halvedlowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 28-08-2026)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 44% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 97+13
equity 71.6% of total assets
Liquidity 40-2
short-term debt 28.4% · cash 1.3%
Profitability 86-1
return on assets 14.1%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.3%▲ +0.1 percentage points vs 09-2025 11-2025: 0.1%▼ -0.2 percentage points vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.2%▲ +0.1 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.1%▼ -0.1 percentage points vs 05-2026 07-2026: 0.2%▲ +0.1 percentage points vs 06-2026 08-2026: 0.3%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.2%▼ -0.1 percentage points vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €15,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.45, compared with 2.99 in 2024, above the usual 1.5; short-term debt: 28.4% and cash: 1.3% of total assets), and 28.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 60% on solvency, 10% on liquidity, 38% on profitability and 68% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
raises risk · Last filed accounts filed 28 days late; 2 of the last 3 late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 3.45, cash €3,062, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 28-08-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
28 days late
2024
60 days late
2023
57 days late
2022
67 days late
2021
73 days late
2020
75 days late
2019
98 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 65 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 September (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €150,000equity €174,119 ▲24.5%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: 6 profitable years in a rowprofit 2025: €34,260 6 years View
  • One director decidessole director in office 1 View
  • Total assets 20256 financial years filed €243,257 View

By topic

Financials

Financial year
2025
Total assets
€243,257
Profit
€34,260
Solvency
71.6%
Total assets▲ 3.3%
Net result
20182025
Go to Financials

Timeline

Events
21
Since
2012
Next accounts
by 31-07-2027
  1. 26-09-2024Annual accounts filed
  2. 05-01-2024Appointment: Charles van der REST (director)
  3. 31-12-2023Highest result from 2018 to 2025
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Founded
09-02-2011
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Articles of association

Provisions read
25
Purpose
“En assurant la gestion d’un centre médical ou d’un cabinet médical,en ce compris…” (deed in French)
Go to Articles of association

Key facts about DR .P.VAN DER REST

What is the company number of DR .P.VAN DER REST?
0833.843.177. In Belgium the VAT number is the company number with BE in front: BE 0833.843.177.
Where is DR .P.VAN DER REST based?
The registered office is at Rue des Jardins-d'Annevoie 32, 5537 Anhée.Company details
What is the legal form of DR .P.VAN DER REST?
Private limited company (BV).
When was DR .P.VAN DER REST founded?
On 09-02-2011.
Is DR .P.VAN DER REST still active?
Yes, DR .P.VAN DER REST is an active enterprise in the KBO register.
What is the turnover of DR .P.VAN DER REST?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR .P.VAN DER REST profitable?
In financial year 2025, DR .P.VAN DER REST made a profit of €34,260.
Where can I find the annual accounts of DR .P.VAN DER REST?
DR .P.VAN DER REST filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR .P.VAN DER REST due?
By 31-07-2027, for financial year 2026.Timeline

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.